Greenspring Associates’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-415,277
| Closed | -$14.1M | – | 6 |
|
|
2021
Q2 | $14.1M | Buy |
415,277
+54,338
| +15% | +$1.84M | 0.95% | 6 |
|
|
2021
Q1 | $13.6M | Hold |
360,939
| – | – | 10.78% | 4 |
|
|
2020
Q4 | $12M | Buy |
360,939
+130,212
| +56% | +$4.33M | 15.57% | 2 |
|
|
2020
Q3 | $8.46M | Sell |
230,727
-150,342
| -39% | -$5.51M | 13.17% | 4 |
|
|
2020
Q2 | $12.5M | Buy |
381,069
+20,130
| +6% | +$662K | 7.7% | 5 |
|
|
2020
Q1 | $9.32M | Hold |
360,939
| – | – | 3.86% | 6 |
|
|
2019
Q4 | $11.2M | Buy |
+360,939
| New | +$11.2M | 2.96% | 7 |
|